Gastroenterologists have welcomed the PBS listing of an eight week pan-genotypic antiviral regimen, glecaprevir/pibrentasvir tablets (Maviret), for people with chronic hepatitis C virus infection. From 1 August Maviret will be available on the PBS as a once-daily eight-week course of treatment-naïve non-cirrhotic patients across all major genotypes (GT1-6) and a 12 week course for those ...
PBS listing for eight-week pan-genotypic antivirals for HCV
By Michael Woodhead
3 Aug 2018